65,437 trials
Meningococcal Vaccines
Primary: Number and Percentage of Participants Experiencing Solicited Events — 12; 10; 7; 0 Participants
Acute Migraine
Primary: Change in Migraine Headache Pain Score From Time of Dosing (0 Minutes) — 0; 0.2; -0.8; -0.2 score on a scale — p=0.9733
Mental Disorder · Substance Use Disorders · Posttraumatic Stress Disorder
Primary: Steady Worker — 26; 15 Participants — p=0.02
Pain · Quality of Life · Injection Site Reaction
Primary: Number of Participants With Injection-Site Pain in Arm That Was Vaccinated, Population 1 — 297; 282; 69; 73 Participants
Brain Cancer
Primary: Number of Participants With High-grade Astrocytoma and Diffuse Pontine Tumors Achieving One Year Progression Free Survival. — 5; 6 Participants
Colon Adenocarcinoma
Primary: Feasibility of 14C Oxaliplatin Microdose as a Clinical Assay to Predict Oxaliplatin Exposure — 0.63 R squared
Healthy
Primary: Oxygen Saturation (SpO2) Accuracy of Sensor — 1.16 % of oxygen saturated hemoglobin
Arterial Hypertension
Primary: The Mean Systolic BP Changes (mm Hg) at the Visit 4 vs. Baseline — 33.47 mm Hg
Mountain Sickness
Primary: Change in Environmental Symptoms Questionnaire at High Altitude — 0.132; 0.122; 0.080; 0.069 score on a scale
Gout · Hyperuricemia
Primary: Uric Acid Level — 8.23; 8.03 mg/dL
Hepatocellular Carcinoma
Primary: Safety and Tolerability — 9; 29; 0; 12 Participants
Insomnia · Primary Insomnia · Chronic Insomnia
Primary: Number of Incorrect Trials During the Computer-administered Attention-Switching Task Test.Attention-Switching Task Latency Error Rate — 5.11; 3.1 trials
Psoriasis
Primary: Percentage of Participants With a Static Physician's Global Assessment (sPGA) of (0,1) With at Least a 2-point Improvement From Baseline — 6.3; 76.3; 79.7 percentage of…
Pharmacokinetics · Epinephrine · Albuterol
Primary: C[Max], Maximum Plasma Concentration of Albuterol or Epinephrine — 240.8; 704.8; 599.8 pg/mL
Healthy
Primary: Oxygen Saturation (SpO2) Accuracy of Sensor — 1.99 % of oxygen saturated hemoglobin